_id
695fb851c2e91020a7bd4284
Ticker
0IFK.LSE
Name
Editas Medicine, Inc.
Exchange
LSE
Address
11 Hurley Street, Cambridge, MA, United States, 02141
Country
UK
Sector
Industry
Currency
USD
Website
https://www.editasmedicine.com
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Last Close
2.13
Volume
100
Current Price
2.13
Change
-0.06
Last Updated
2026-01-08T13:59:45.188Z
Ipo Date
-
Market Cap
10036644000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
7543000
Cost Of Revenue
-
Gross Profit
7543000
Operating Expenses
32091000
Operating Income
-24548000
Interest Expense
2399000
Pretax Income
-25117000
Net Income
-25117000
Eps
-0.2787977502197043
Dividends Per Share
-
Shares Outstanding
47495600
Income Tax Expense
-
EBITDA
-21997000
Operating Margin
-325.4408060453401
Total Other Income Expense Net
-569000
Cash
165648000
Short Term Investments
-
Receivables
8130000
Inventories
-
Total Current Assets
176891000
Property Plant Equipment
21870000
Total Assets
201751000
Payables
3163000
Short Term Debt
6088000
Long Term Debt
-
Total Liabilities
188298000
Equity
13453000
Bs_currency_symbol
-
Depreciation
721000
Change In Working Capital
-11012000
Cash From Operations
-30843000
Capital Expenditures
433000
Cash From Investing
39573000
Cash From Financing
17169000
Net Change In Cash
25899000
Cf_currency_symbol
-
PE
-
PB
14.263922218835948
ROE
-186.7018508882777
ROA
-12.449504587337858
FCF
-31276000
Fcf Percent
-4.146360864377568
Piotroski FScore
0
Health Score
8
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
2
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
7543000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
7543000
Quarters > 0 > income Statement > operating Expenses
32091000
Quarters > 0 > income Statement > operating Income
-24548000
Quarters > 0 > income Statement > interest Expense
2399000
Quarters > 0 > income Statement > pretax Income
-25117000
Quarters > 0 > income Statement > net Income
-25117000
Quarters > 0 > income Statement > eps
-0.2787977502197043
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
90090397
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-21997000
Quarters > 0 > income Statement > operating Margin
-325.4408060453401
Quarters > 0 > income Statement > total Other Income Expense Net
-569000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
165648000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
8130000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
176891000
Quarters > 0 > balance Sheet > property Plant Equipment
21870000
Quarters > 0 > balance Sheet > total Assets
201751000
Quarters > 0 > balance Sheet > payables
3163000
Quarters > 0 > balance Sheet > short Term Debt
6088000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
188298000
Quarters > 0 > balance Sheet > equity
13453000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-25117000
Quarters > 0 > cash Flow > depreciation
721000
Quarters > 0 > cash Flow > change In Working Capital
-11012000
Quarters > 0 > cash Flow > cash From Operations
-30843000
Quarters > 0 > cash Flow > capital Expenditures
433000
Quarters > 0 > cash Flow > cash From Investing
39573000
Quarters > 0 > cash Flow > cash From Financing
17169000
Quarters > 0 > cash Flow > net Change In Cash
25899000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.2787977502197043
Quarters > 0 > ratios > PB
14.263922218835948
Quarters > 0 > ratios > ROE
-186.7018508882777
Quarters > 0 > ratios > ROA
-12.449504587337858
Quarters > 0 > ratios > FCF
-31276000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-4.146360864377568
Quarters > 0 > health Score
8
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
3578000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
3578000
Quarters > 1 > income Statement > operating Expenses
55122000
Quarters > 1 > income Statement > operating Income
-51544000
Quarters > 1 > income Statement > interest Expense
2020000
Quarters > 1 > income Statement > pretax Income
-53235000
Quarters > 1 > income Statement > net Income
-53235000
Quarters > 1 > income Statement > eps
-0.630655284425711
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
84412200
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-49381000
Quarters > 1 > income Statement > operating Margin
-1440.581330352152
Quarters > 1 > income Statement > total Other Income Expense Net
-1691000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
138542000
Quarters > 1 > balance Sheet > short Term Investments
39959000
Quarters > 1 > balance Sheet > receivables
588000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
182796000
Quarters > 1 > balance Sheet > property Plant Equipment
23587000
Quarters > 1 > balance Sheet > total Assets
210581000
Quarters > 1 > balance Sheet > payables
6723000
Quarters > 1 > balance Sheet > short Term Debt
6146000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
191392000
Quarters > 1 > balance Sheet > equity
19189000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-53235000
Quarters > 1 > cash Flow > depreciation
1577000
Quarters > 1 > cash Flow > change In Working Capital
-4620000
Quarters > 1 > cash Flow > cash From Operations
-50212000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
42650000
Quarters > 1 > cash Flow > cash From Financing
7412000
Quarters > 1 > cash Flow > net Change In Cash
-150000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.630655284425711
Quarters > 1 > ratios > PB
9.369846578769087
Quarters > 1 > ratios > ROE
-277.4245661576945
Quarters > 1 > ratios > ROA
-25.280058504803378
Quarters > 1 > ratios > FCF
-50212000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-14.033538289547232
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
4658000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
4658000
Quarters > 2 > income Statement > operating Expenses
80821000
Quarters > 2 > income Statement > operating Income
-76163000
Quarters > 2 > income Statement > interest Expense
2216000
Quarters > 2 > income Statement > pretax Income
-76088000
Quarters > 2 > income Statement > net Income
-76088000
Quarters > 2 > income Statement > eps
-0.9161150988670577
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
83055066
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-71955000
Quarters > 2 > income Statement > operating Margin
-1635.1009016745384
Quarters > 2 > income Statement > total Other Income Expense Net
75000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
138692000
Quarters > 2 > balance Sheet > short Term Investments
82272000
Quarters > 2 > balance Sheet > receivables
510000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
224843000
Quarters > 2 > balance Sheet > property Plant Equipment
34611000
Quarters > 2 > balance Sheet > total Assets
263652000
Quarters > 2 > balance Sheet > payables
5465000
Quarters > 2 > balance Sheet > short Term Debt
13161000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
201232000
Quarters > 2 > balance Sheet > equity
62420000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-76088000
Quarters > 2 > cash Flow > depreciation
1917000
Quarters > 2 > cash Flow > change In Working Capital
17615000
Quarters > 2 > cash Flow > cash From Operations
-47799000
Quarters > 2 > cash Flow > capital Expenditures
114000
Quarters > 2 > cash Flow > cash From Investing
56387000
Quarters > 2 > cash Flow > cash From Financing
-1437000
Quarters > 2 > cash Flow > net Change In Cash
7151000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.9161150988670577
Quarters > 2 > ratios > PB
2.834144354053188
Quarters > 2 > ratios > ROE
-121.89682793976289
Quarters > 2 > ratios > ROA
-28.859253864943184
Quarters > 2 > ratios > FCF
-47913000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-10.286174323744095
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
30604000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
30604000
Quarters > 3 > income Statement > operating Expenses
77197000
Quarters > 3 > income Statement > operating Income
-46593000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-45395000
Quarters > 3 > income Statement > net Income
-45395000
Quarters > 3 > income Statement > eps
-0.5494842625080539
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
82613831
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-32980000
Quarters > 3 > income Statement > operating Margin
-152.2448046007058
Quarters > 3 > income Statement > total Other Income Expense Net
1198000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
131541000
Quarters > 3 > balance Sheet > short Term Investments
138372000
Quarters > 3 > balance Sheet > receivables
16266000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
289315000
Quarters > 3 > balance Sheet > property Plant Equipment
47051000
Quarters > 3 > balance Sheet > total Assets
341589000
Quarters > 3 > balance Sheet > payables
5493000
Quarters > 3 > balance Sheet > short Term Debt
14652000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
207315000
Quarters > 3 > balance Sheet > equity
134274000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-45395000
Quarters > 3 > cash Flow > depreciation
1381000
Quarters > 3 > cash Flow > change In Working Capital
-12099000
Quarters > 3 > cash Flow > cash From Operations
-50762000
Quarters > 3 > cash Flow > capital Expenditures
540000
Quarters > 3 > cash Flow > cash From Investing
30958000
Quarters > 3 > cash Flow > cash From Financing
55513000
Quarters > 3 > cash Flow > net Change In Cash
35709000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.5494842625080539
Quarters > 3 > ratios > PB
1.31051030005809
Quarters > 3 > ratios > ROE
-33.80773641956
Quarters > 3 > ratios > ROA
-13.289362362371154
Quarters > 3 > ratios > FCF
-51302000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.676316821330545
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
32314000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
32314000
Annuals > 0 > income Statement > operating Expenses
283466000
Annuals > 0 > income Statement > operating Income
-251152000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-237093000
Annuals > 0 > income Statement > net Income
-237093000
Annuals > 0 > income Statement > eps
-2.879501159971639
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
82338220
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-233111000
Annuals > 0 > income Statement > operating Margin
-777.2234944606053
Annuals > 0 > income Statement > total Other Income Expense Net
14059000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
131541000
Annuals > 0 > balance Sheet > short Term Investments
138372000
Annuals > 0 > balance Sheet > receivables
16266000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
289315000
Annuals > 0 > balance Sheet > property Plant Equipment
47051000
Annuals > 0 > balance Sheet > total Assets
341589000
Annuals > 0 > balance Sheet > payables
5493000
Annuals > 0 > balance Sheet > short Term Debt
14652000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
207315000
Annuals > 0 > balance Sheet > equity
134274000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-237093000
Annuals > 0 > cash Flow > depreciation
5809000
Annuals > 0 > cash Flow > change In Working Capital
3450000
Annuals > 0 > cash Flow > cash From Operations
-210284000
Annuals > 0 > cash Flow > capital Expenditures
8826000
Annuals > 0 > cash Flow > cash From Investing
162146000
Annuals > 0 > cash Flow > cash From Financing
56027000
Annuals > 0 > cash Flow > net Change In Cash
7889000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-2.879501159971639
Annuals > 0 > ratios > PB
1.3061382590821753
Annuals > 0 > ratios > ROE
-176.5740202868761
Annuals > 0 > ratios > ROA
-69.40885098759036
Annuals > 0 > ratios > FCF
-219110000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-6.780652348827134
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
78123000
Annuals > 1 > income Statement > cost Of Revenue
6064000
Annuals > 1 > income Statement > gross Profit
72059000
Annuals > 1 > income Statement > operating Expenses
241240000
Annuals > 1 > income Statement > operating Income
-169181000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-153219000
Annuals > 1 > income Statement > net Income
-153219000
Annuals > 1 > income Statement > eps
-2.016951533860055
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
75965633
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-163117000
Annuals > 1 > income Statement > operating Margin
-216.55722386493093
Annuals > 1 > income Statement > total Other Income Expense Net
15962000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
123652000
Annuals > 1 > balance Sheet > short Term Investments
199459000
Annuals > 1 > balance Sheet > receivables
10187000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
340829000
Annuals > 1 > balance Sheet > property Plant Equipment
45712000
Annuals > 1 > balance Sheet > total Assets
499153000
Annuals > 1 > balance Sheet > payables
8269000
Annuals > 1 > balance Sheet > short Term Debt
24167000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
150056000
Annuals > 1 > balance Sheet > equity
349097000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-153219000
Annuals > 1 > cash Flow > depreciation
6064000
Annuals > 1 > cash Flow > change In Working Capital
-1594000
Annuals > 1 > cash Flow > cash From Operations
-132178000
Annuals > 1 > cash Flow > capital Expenditures
4719000
Annuals > 1 > cash Flow > cash From Investing
-3731000
Annuals > 1 > cash Flow > cash From Financing
118039000
Annuals > 1 > cash Flow > net Change In Cash
-17870000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.016951533860055
Annuals > 1 > ratios > PB
0.4635009704752547
Annuals > 1 > ratios > ROE
-43.89009358430465
Annuals > 1 > ratios > ROA
-30.69579868296895
Annuals > 1 > ratios > FCF
-136897000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.7523264595573647
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
19712000
Annuals > 2 > income Statement > cost Of Revenue
6337000
Annuals > 2 > income Statement > gross Profit
13375000
Annuals > 2 > income Statement > operating Expenses
239325000
Annuals > 2 > income Statement > operating Income
-225950000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-220432000
Annuals > 2 > income Statement > net Income
-220432000
Annuals > 2 > income Statement > eps
-3.2102609979823438
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
68664822
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-219613000
Annuals > 2 > income Statement > operating Margin
-1146.2560876623377
Annuals > 2 > income Statement > total Other Income Expense Net
5518000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
141522000
Annuals > 2 > balance Sheet > short Term Investments
202752000
Annuals > 2 > balance Sheet > receivables
5145000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
356754000
Annuals > 2 > balance Sheet > property Plant Equipment
59217000
Annuals > 2 > balance Sheet > total Assets
514321000
Annuals > 2 > balance Sheet > payables
9511000
Annuals > 2 > balance Sheet > short Term Debt
11082000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
153641000
Annuals > 2 > balance Sheet > equity
360680000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-220432000
Annuals > 2 > cash Flow > depreciation
6337000
Annuals > 2 > cash Flow > change In Working Capital
8176000
Annuals > 2 > cash Flow > cash From Operations
-177349000
Annuals > 2 > cash Flow > capital Expenditures
4118000
Annuals > 2 > cash Flow > cash From Investing
114068000
Annuals > 2 > cash Flow > cash From Financing
1284000
Annuals > 2 > cash Flow > net Change In Cash
-61997000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3.2102609979823438
Annuals > 2 > ratios > PB
0.4055009173228346
Annuals > 2 > ratios > ROE
-61.11567040035488
Annuals > 2 > ratios > ROA
-42.85883718533756
Annuals > 2 > ratios > FCF
-181467000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-9.205915178571429
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
25544000
Annuals > 3 > income Statement > cost Of Revenue
5053000
Annuals > 3 > income Statement > gross Profit
20491000
Annuals > 3 > income Statement > operating Expenses
213637000
Annuals > 3 > income Statement > operating Income
-193146000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-192502000
Annuals > 3 > income Statement > net Income
-192502000
Annuals > 3 > income Statement > eps
-2.846846232917695
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
67619388
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-188093000
Annuals > 3 > income Statement > operating Margin
-756.1305981835264
Annuals > 3 > income Statement > total Other Income Expense Net
644000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
203519000
Annuals > 3 > balance Sheet > short Term Investments
296326000
Annuals > 3 > balance Sheet > receivables
267000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
507310000
Annuals > 3 > balance Sheet > property Plant Equipment
43291000
Annuals > 3 > balance Sheet > total Assets
677483000
Annuals > 3 > balance Sheet > payables
5050000
Annuals > 3 > balance Sheet > short Term Debt
10309000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
123841000
Annuals > 3 > balance Sheet > equity
553642000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-192502000
Annuals > 3 > cash Flow > depreciation
5053000
Annuals > 3 > cash Flow > change In Working Capital
-21410000
Annuals > 3 > cash Flow > cash From Operations
-163803000
Annuals > 3 > cash Flow > capital Expenditures
7977000
Annuals > 3 > cash Flow > cash From Investing
-54466000
Annuals > 3 > cash Flow > cash From Financing
282106000
Annuals > 3 > cash Flow > net Change In Cash
63837000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-2.846846232917695
Annuals > 3 > ratios > PB
0.26014879008456726
Annuals > 3 > ratios > ROE
-34.77012220893646
Annuals > 3 > ratios > ROA
-28.414292314345897
Annuals > 3 > ratios > FCF
-171780000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-6.724866896335734
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.2787977502197043
Valuation > metrics > PB
14.263922218835948
Valuation > final Score
20
Valuation > verdict
375.5% Overvalued
Profitability > metrics > ROE
-186.7018508882777
Profitability > metrics > ROA
-14.199139583133116
Profitability > metrics > Net Margin
-3.3298422378364045
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
13.996729354047424
Risk > metrics > Interest Coverage
-10.232596915381409
Risk > final Score
-35
Risk > verdict
High
Liquidity > metrics > Current Ratio
19.12128418549346
Liquidity > metrics > Quick Ratio
19.12128418549346
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-96
Prev Risks > 1
-131
Prev Risks > 2
15
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-23T20:09:41.597Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-11
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.21
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Editas Medicine, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.21
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.